Guoji Yanke Zazhi (May 2015)

Profiles of glaucoma medication

  • Yan-Qing Yang,
  • Yan Li

DOI
https://doi.org/10.3980/j.issn.1672-5123.2015.5.16
Journal volume & issue
Vol. 15, no. 5
pp. 807 – 809

Abstract

Read online

As a globally recognized irreversible blindness disease, glaucoma can lead to pathological intraocular hypertension, loss of optic ganglion cells and axonal progressive, more and more deep optic cup, and the expanded visual field defect. Various researches show that excitatory amino acid toxicity, oxidative damage, apoptosis, intracellular Ca2+overloading etc., pathogenic factors are all involved in the occurrence and development of glaucoma. Now, a variety of clinical drugs and operation treatment are applied to control the glaucoma progress. Further more, there are many new drugs and methods in the process of development. This is an article on the current anti-glaucoma drugs.

Keywords